Palisade Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Palisade Bio
PALI Stock  USD 0.80  0.05  5.88%   
Palisade Bio financial statements provide useful quarterly and yearly information to potential Palisade Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Palisade Bio financial statements helps investors assess Palisade Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Palisade Bio's valuation are summarized below:
Market Capitalization
2.5 M
Enterprise Value Revenue
234.8894
Earnings Share
(13.26)
We have found one hundred twenty available trending fundamental ratios for Palisade Bio, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Palisade Bio recent fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 4.4 M. The Palisade Bio's current Enterprise Value is estimated to increase to about (8.8 M)

Palisade Bio Total Revenue

165,400

Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 K, Interest Expense of 16.4 K or Selling General Administrative of 6.6 M, as well as many indicators such as Price To Sales Ratio of 13.8, Dividend Yield of 0.0 or PTB Ratio of 0.39. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
  
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Palisade Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.3 M16.2 M12.7 M
Very volatile
Short and Long Term Debt Total315.5 K332.1 K3 M
Slightly volatile
Other Current Liabilities1.5 M1.9 M1.3 M
Pretty Stable
Total Current Liabilities3.4 M3 M3.4 M
Very volatile
Property Plant And Equipment Net233.1 K239.2 K224.3 K
Very volatile
Accounts Payable1.5 M802.7 K1.3 M
Very volatile
Cash8.5 M14.3 M8.6 M
Slightly volatile
Non Current Assets Total1.1 M832.6 K1.2 M
Pretty Stable
Non Currrent Assets Other321.3 K593.4 K372.5 K
Slightly volatile
Cash And Short Term Investments10.4 M14.3 M10.7 M
Very volatile
Common Stock Total Equity147.9 K155.7 K342.7 K
Slightly volatile
Common Stock Shares Outstanding550.6 K524.4 K107.8 K
Slightly volatile
Liabilities And Stockholders Equity12.3 M16.2 M12.7 M
Very volatile
Non Current Liabilities Total130.8 K137.7 K2.5 M
Pretty Stable
Other Current Assets542.6 K860.2 K581.4 K
Slightly volatile
Other Stockholder Equity140.2 M152.6 M144.9 M
Pretty Stable
Total Liabilities6.2 M3.1 M6.1 M
Very volatile
Property Plant And Equipment Gross218.2 K239.2 K208.1 K
Very volatile
Total Current Assets11.2 M15.3 M11.6 M
Pretty Stable
Short Term Debt238.5 K251.1 K1.2 M
Slightly volatile
Intangible Assets160.7 K169.2 K576.6 K
Slightly volatile
Common Stock79.5 K83.7 K309.1 K
Slightly volatile
Net Receivables264.5 K170.2 K207.9 K
Slightly volatile
Short Term Investments13.7 K14.4 K5.8 M
Slightly volatile
Other Assets48.2 K29.9 K30.4 K
Slightly volatile
Capital Surpluse245.4 M285 M225.9 M
Slightly volatile
Property Plant Equipment167.9 K100.8 K210.6 K
Slightly volatile
Other Liabilities1.7 M3 M1.1 M
Slightly volatile
Long Term Debt75.2 K84.6 K92.2 K
Slightly volatile
Capital Lease Obligations183.8 K189.9 K255.8 K
Slightly volatile
Deferred Long Term Liabilities1.5 M1.6 M1.8 M
Slightly volatile
Short and Long Term Debt276 K142.2 K766.8 K
Slightly volatile
Capital Stock82.5 K109.2 K48.2 K
Slightly volatile
Non Current Liabilities Other53.9 K56.7 K1.4 M
Slightly volatile

Palisade Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4.4 K4.6 K177.5 K
Slightly volatile
Interest Expense16.4 K17.2 K553.5 K
Pretty Stable
Selling General Administrative6.6 M7.1 M6.3 M
Slightly volatile
Other Operating Expenses15.4 M15.3 M14.9 M
Slightly volatile
Research Development8.9 M7.9 M8.6 M
Pretty Stable
Total Operating Expenses15.4 M15.3 M14.9 M
Slightly volatile
Interest Income24.6 K25.9 K536.2 K
Pretty Stable
Selling And Marketing Expenses3.4 K3.6 K1.8 M
Slightly volatile
Cost Of Revenue3.4 K3.6 K122 K
Slightly volatile
Reconciled Depreciation3.3 K4.6 K3.1 K
Slightly volatile

Palisade Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation533.5 K561.6 K1.9 M
Slightly volatile
Begin Period Cash Flow7.6 M14.3 M8.2 M
Pretty Stable
Depreciation3.4 K3.6 K147.8 K
Slightly volatile
Total Cash From Financing Activities11.7 M12.9 M11.4 M
Very volatile
End Period Cash Flow8.5 M14.3 M8.6 M
Slightly volatile
Change To Netincome17.2 M16.4 M5.9 M
Slightly volatile
Issuance Of Capital Stock13.8 M10.8 M5.4 M
Slightly volatile
Dividends Paid79.2 K89.1 K97.1 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.814.53150.2 K
Slightly volatile
Days Sales Outstanding236248712
Pretty Stable
Average Payables667.8 K768.4 K1.1 M
Slightly volatile
Stock Based Compensation To Revenue2.132.2571.442
Pretty Stable
Capex To Depreciation2.123.832.0027
Slightly volatile
Sales General And Administrative To Revenue21.2122.33170
Pretty Stable
Research And Ddevelopement To Revenue23.5724.81200
Pretty Stable
Capex To Revenue0.01370.01444.4357
Slightly volatile
Cash Per Share29.7831.354.7 K
Slightly volatile
Income Quality0.590.810.7606
Pretty Stable
Intangibles To Total Assets0.05230.09140.0826
Pretty Stable
Current Ratio3.244.643.9422
Slightly volatile
Receivables Turnover1.851.948.6002
Slightly volatile
Capex Per Share0.00960.0101155
Slightly volatile
Average Receivables135.6 K170.6 K207.8 K
Pretty Stable
Revenue Per Share0.60.632.2 K
Slightly volatile
Interest Debt Per Share0.920.972.1 K
Slightly volatile
Debt To Assets0.02870.03020.274
Slightly volatile
Ebt Per Ebit1.131.081.0369
Slightly volatile
Quick Ratio3.274.643.9949
Slightly volatile
Net Income Per E B T1.091.031.0093
Very volatile
Cash Ratio2.654.333.0488
Slightly volatile
Days Of Sales Outstanding236248712
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.121.151.0324
Pretty Stable
Fixed Asset Turnover2.51.381.6454
Slightly volatile
Debt Ratio0.02870.03020.274
Slightly volatile
Price Sales Ratio13.814.53150.2 K
Slightly volatile
Asset Turnover0.01940.02050.0528
Slightly volatile

Palisade Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.4 M4.6 M4.2 B
Slightly volatile

Palisade Fundamental Market Drivers

Cash And Short Term Investments12.4 M

Palisade Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Palisade Bio Financial Statements

Investors use fundamental indicators, such as Palisade Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Palisade Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-323.8 K-340 K
Total Revenue225 K165.4 K
Cost Of Revenue3.6 K3.4 K
Stock Based Compensation To Revenue 2.25  2.13 
Sales General And Administrative To Revenue 22.33  21.21 
Research And Ddevelopement To Revenue 24.81  23.57 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.63  0.60 
Ebit Per Revenue(60.12)(63.13)

Currently Active Assets on Macroaxis

VVisa Class A
CRMSalesforce
CRMSalesforce
MSFTMicrosoft
VVisa Class A
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
How To Invest In Palisade
Details
Is Palisade Stock a good investment?
Details
What is Palisade Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.26)
Return On Assets
(0.68)
Return On Equity
(1.36)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY